Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 106

1.

A reporting framework for describing and a typology for categorizing and analyzing the designs of health care pay for performance schemes.

Ogundeji YK, Sheldon TA, Maynard A.

BMC Health Serv Res. 2018 Sep 4;18(1):686. doi: 10.1186/s12913-018-3479-x.

2.

Redistribution and redesign in health care: An ebbing tide in England versus growing concerns in the United States.

Maynard A, Altman SH, Stearns SC.

Health Econ. 2017 Jun;26(6):687-690. doi: 10.1002/hec.3516. No abstract available.

PMID:
28470833
3.

Shrinking the state: The fate of the NHS and social care.

Maynard A.

J R Soc Med. 2017 Feb;110(2):49-51. doi: 10.1177/0141076816686923. No abstract available.

PMID:
28169585
4.

Should the NHS abolish the purchaser-provider split?

Maynard A, Dixon M.

BMJ. 2016 Jul 12;354:i3825. doi: 10.1136/bmj.i3825. No abstract available.

PMID:
27406100
5.

Hospital Surgical Volumes and Mortality after Coronary Artery Bypass Grafting: Using International Comparisons to Determine a Safe Threshold.

Gutacker N, Bloor K, Cookson R, Gale CP, Maynard A, Pagano D, Pomar J, Bernal-Delgado E; as part of the ECHO collaboration.

Health Serv Res. 2017 Apr;52(2):863-878. doi: 10.1111/1475-6773.12508. Epub 2016 May 16.

6.

The death of death rates?

Doran T, Bloor K, Maynard A.

BMJ. 2015 Jul 14;351:h3466. doi: 10.1136/bmj.h3466. No abstract available.

PMID:
26174623
7.

Put all GPs on a salaried contract.

Maynard A.

BMJ. 2015 Apr 30;350:h2254. doi: 10.1136/bmj.h2254. No abstract available.

PMID:
25929537
8.

Regulation of the pharmaceutical industry: promoting health or protecting wealth?

Maynard A, Bloor K.

J R Soc Med. 2015 Jun;108(6):220-2. doi: 10.1177/0141076814568299. Epub 2015 Apr 28. No abstract available.

9.

Women in medicine: historical perspectives and recent trends.

Jefferson L, Bloor K, Maynard A.

Br Med Bull. 2015 Jun;114(1):5-15. doi: 10.1093/bmb/ldv007. Epub 2015 Mar 8.

PMID:
25755293
10.

Variations in health care delivery within the European Union.

Peiró S, Maynard A.

Eur J Public Health. 2015 Feb;25 Suppl 1:1-2. doi: 10.1093/eurpub/cku223. No abstract available.

PMID:
25690122
11.

International experience in controlling pharmaceutical expenditure: influencing patients and providers and regulating industry - a systematic review.

Lee IH, Bloor K, Hewitt C, Maynard A.

J Health Serv Res Policy. 2015 Jan;20(1):52-9. doi: 10.1177/1355819614545675. Epub 2014 Aug 4. Review.

12.

NHS England chief executive: welcome back, Simon. Here's your to-do list.

Appleby J, Charles A, Maynard A, Kar P, Gerada C, Prabhu U, O'Riordan D, Wood J, Alessi C, Doyle A, Dixon M, Kell S, Bell A, Dalton S, Rodrigues L, Coghill Y, Kline R, Morgan B, Farrington-Douglas J, Foster A, Humphries R, Keene S, Koczan P.

Health Serv J. 2014 Apr 4;124(6393):16-9. No abstract available.

PMID:
24956712
13.

Using evidence to meet population healthcare needs: A UK perspective.

Bloor K, Maynard A.

Healthc Pap. 2013;13(2):42-5; discussion 52-5.

PMID:
24131815
14.

Economics: the biggest fraud ever perpetrated on the world?

Parkin D, Appleby J, Maynard A.

Lancet. 2013 Oct 12;382(9900):e11-5. doi: 10.1016/S0140-6736(13)61178-2. Epub 2013 Oct 2. No abstract available.

PMID:
24095177
15.

Health care rationing: doing it better in public and private health care systems.

Maynard A.

J Health Polit Policy Law. 2013 Dec;38(6):1103-27. doi: 10.1215/03616878-2373157. Epub 2013 Aug 23.

PMID:
23974472
16.

Should the chancellor of the exchequer lift the ringfence on England's health budget?

Cawston T, Maynard A.

BMJ. 2013 Jun 26;346:f4126. doi: 10.1136/bmj.f4126. No abstract available.

PMID:
23804294
17.

NHS reform: the risks of jumping on the spot again.

Maynard A.

J R Soc Med. 2013 May;106(5):164-6. doi: 10.1177/0141076813487282. No abstract available.

18.

Funding health care in times of austerity: what goes around comes around.

Maynard A.

J Health Serv Res Policy. 2013 Jan;18(1):1-2. doi: 10.1258/jhsrp.2012.012041. No abstract available.

PMID:
23393033
19.

Trends in consultant clinical activity and the effect of the 2003 contract change: retrospective analysis of secondary data.

Bloor K, Freemantle N, Maynard A.

J R Soc Med. 2012 Nov;105(11):472-9. doi: 10.1258/jrsm.2012.120130. Epub 2012 Dec 13.

20.

Reform of the clinical excellence awards scheme: why are we waiting?

Bloor K, Maynard A.

J R Soc Med. 2012 Sep;105(9):368-72. doi: 10.1258/jrsm.2012.120035. No abstract available.

21.

Time to reform primary care?

Maynard A.

J R Soc Med. 2012 Jun;105(6):247-9. doi: 10.1258/jrsm.2012.12k032. No abstract available.

22.

Privatisation: an exercise in ambiguity and ideology.

Maynard A.

Br J Gen Pract. 2012 Apr;62(597):174-5. doi: 10.3399/bjgp12X635967. No abstract available.

23.

Dealing with variation.

Maynard A.

Health Serv J. 2012 Jan 12;122(6289):16. No abstract available.

PMID:
22393854
24.

Early appraisal of China's huge and complex health-care reforms.

Yip WC, Hsiao WC, Chen W, Hu S, Ma J, Maynard A.

Lancet. 2012 Mar 3;379(9818):833-42. doi: 10.1016/S0140-6736(11)61880-1. Review.

PMID:
22386036
25.

Public health and economics: a marriage of necessity.

Maynard A.

J Public Health Res. 2012 Feb 14;1(1):11-3. doi: 10.4081/jphr.2012.e4. eCollection 2012 Feb 17.

26.

The powers and pitfalls of payment for performance.

Maynard A.

Health Econ. 2012 Jan;21(1):3-12. doi: 10.1002/hec.1810. Review. No abstract available.

PMID:
22147622
27.

What is cost effective is always effective.

Maynard A.

BMJ. 2011 Nov 29;343:d7699. doi: 10.1136/bmj.d7699. No abstract available.

PMID:
22127447
28.

The effects of new pricing and copayment schemes for pharmaceuticals in South Korea.

Lee IH, Bloor K, Hewitt C, Maynard A.

Health Policy. 2012 Jan;104(1):40-9. doi: 10.1016/j.healthpol.2011.09.003. Epub 2011 Oct 14.

PMID:
22000599
29.

'Inert' or improving: the state of medical regulation. Rivalry breeds quality.

Maynard A.

Health Serv J. 2011 Aug 25;121(6271):17. No abstract available.

PMID:
21998995
30.

Commentary: Clinical freedom is dead and no one need regret its passing.

Maynard A.

Int J Epidemiol. 2011 Aug;40(4):858-9. doi: 10.1093/ije/dyr047. No abstract available.

PMID:
21846659
31.

Using 'payment by results' to fund the treatment of dependent drug users--proceed with care!

Maynard A, Street A, Hunter R.

Addiction. 2011 Oct;106(10):1725-9. doi: 10.1111/j.1360-0443.2011.03503.x. Epub 2011 Jul 27.

PMID:
21793968
32.

NHS reform--irrelevant at best?

Maynard A.

Health Serv J. 2011 Apr 28;121(6254):12. No abstract available.

PMID:
21608186
33.

The economics of the NHS cancer drugs fund.

Maynard A, Bloor K.

Appl Health Econ Health Policy. 2011 May 1;9(3):137-8. doi: 10.2165/11585750-000000000-00000. No abstract available.

PMID:
21506619
34.

Is quality of care improving? What about value for money?

Maynard A.

BMJ. 2011 Mar 1;342:d1319. doi: 10.1136/bmj.d1319. No abstract available.

PMID:
21363853
35.

The big chill will hit medics too.

Maynard A.

Health Serv J. 2010 Dec 17;120(6237):14-5. No abstract available.

PMID:
21290813
36.

The future role of NICE.

Maynard A, Bloor K.

BMJ. 2010 Nov 8;341:c6286. doi: 10.1136/bmj.c6286. No abstract available.

PMID:
21059728
37.

Complete the picture.

Maynard A.

Nurs Older People. 2010 Oct;22(8):9. No abstract available.

PMID:
21049863
38.

Reforming the English NHS: a continuing journey.

Bloor K, Maynard A.

Appl Health Econ Health Policy. 2010;8(6):373-5. doi: 10.2165/11586180-000000000-00000. No abstract available.

PMID:
21043538
39.

The new healthcare revolution.

Maynard A.

Health Serv J. 2010 Jul 29;120(6217):14-5. No abstract available.

PMID:
20824932
40.

Shifting the deckchairs on the NHS Titanic.

Maynard A.

J R Soc Med. 2010 Aug 1;103(8):304-5. doi: 10.1258/jrsm.2010.10k041. No abstract available.

41.

All trained up, nowhere to go?

Maynard A.

Health Serv J. 2010 Jun 10;120(6210):14-5. No abstract available.

PMID:
20614549
42.

Predictions for productivity. The axe must swing on jobs and pay.

Maynard A.

Health Serv J. 2010 Apr 22;120(6203):14-5. No abstract available.

PMID:
20509201
43.

How will the Tories reform the NHS?

Maynard A.

J R Soc Med. 2010 May;103(5):168-72. doi: 10.1258/jrsm.2010.100124. No abstract available.

44.

On commissioning. Could the Tories give PCTs bite?

Maynard A.

Health Serv J. 2010 Feb 18;120(6194):16-7. No abstract available.

PMID:
20405568
45.

Patient reported outcome measurement: learning to walk before we run.

Maynard A, Bloor K.

J R Soc Med. 2010 Apr;103(4):129-32. doi: 10.1258/jrsm.2010.090477. No abstract available.

46.

Will financial incentives and penalties improve hospital care?

Maynard A, Bloor K.

BMJ. 2010 Jan 21;340:c88. doi: 10.1136/bmj.c88. No abstract available.

PMID:
20093280
47.

The economic impact of pandemic influenza.

Maynard A, Bloor K.

BMJ. 2009 Nov 19;339:b4888. doi: 10.1136/bmj.b4888. No abstract available.

PMID:
19926698
48.

Alan Maynard on whether investment in 'quality' saves money.

Maynard A.

Health Serv J. 2009 Jun 18;Suppl:8. No abstract available.

PMID:
19658255
49.

Health economics in China. Foreword.

Hsiao WC, Maynard A.

Health Econ. 2009 Jul;18 Suppl 2:S1-2. doi: 10.1002/hec.1516. No abstract available.

PMID:
19551755
50.

NICE wobbles.

Maynard A, Bloor K.

J R Soc Med. 2009 Jun;102(6):212-3. doi: 10.1258/jrsm.2009.09k031. No abstract available.

Supplemental Content

Loading ...
Support Center